Title
Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas
Date Issued
16 January 2018
Access level
metadata only access
Resource Type
journal article
Author(s)
Genere N.
Clínica Mayo
Publisher(s)
American College of Physicians
Start page
JC8
Volume
168
Issue
2
Language
English
OCDE Knowledge area
Endocrinología, Metabolismo (incluyendo diabetes, hormonas)
Publication version
Version of Record
Scopus EID
2-s2.0-85044415384
PubMed ID
Source
Annals of Internal Medicine
ISSN of the container
00034819
Sources of information:
Directorio de Producción Científica
Scopus